Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
19.02
+0.92 (5.08%)
Mar 6, 2026, 4:08 PM HKT
-40.56% (1Y)
| Market Cap | 2.59B |
| Revenue (ttm) | 2.34M -13.4% |
| Net Income | -123.26M |
| EPS | -11.28 |
| Shares Out | 136.22M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 451,500 |
| Average Volume | 121,554 |
| Open | 18.00 |
| Previous Close | 18.10 |
| Day's Range | 18.00 - 19.48 |
| 52-Week Range | 13.48 - 32.00 |
| Beta | 0.84 |
| RSI | 53.40 |
| Earnings Date | n/a |